325767

Sigma-Aldrich

Lanthanum(III) carbonate hydrate

99.9% trace metals basis

Linear Formula:
La2(CO3)3·xH2O
CAS Number:
Molecular Weight:
457.84 (anhydrous basis)
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.23

assay

99.9% trace metals basis

form

powder

composition

Degree of hydration, 2-5

reaction suitability

reagent type: catalyst
core: lanthanum

impurities

≤ 1500.0  ppm Trace Rare Earth Analysis

SMILES string

O.[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O

InChI

1S/3CH2O3.2La.H2O/c3*2-1(3)4;;;/h3*(H2,2,3,4);;;1H2/q;;;2*+3;/p-6

InChI key

AFCUGQOTNCVYSW-UHFFFAOYSA-H

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Precautionary Statements

Target Organs

Respiratory system

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

NONH for all modes of transport

WGK Germany

nwg

Certificate of Analysis
Certificate of Origin
Stefan P Schumacher et al.
Nephrology (Carlton, Vic.), 24(2), 221-226 (2018-02-27)
Hyperphosphataemia is associated with increased mortality and morbidity in end stage renal disease. Despite phosphate binder therapy, a large proportion of patients do not reach the treatment target. In five contemporary binders we explored the influence of pH and phosphate...
Reiko Inoue et al.
Clinical and experimental nephrology, 23(6), 859-864 (2019-03-02)
This study aims to describe the regional variance in prescriptions for chronic kidney disease (CKD) medications and to analyze regional characteristics to identify the sources of these differences by utilizing the National Database of Health Insurance Claims, which provides more...
Atsushi Yaguchi et al.
PloS one, 12(7), e0180430-e0180430 (2017-07-14)
The effects of PA21, a novel iron-based and non-calcium-based phosphate binder, on hyperphosphatemia and its accompanying bone abnormality in chronic kidney disease-mineral and bone disorder (CKD-MBD) were evaluated. Rats with adenine-induced chronic renal failure (CRF) were prepared by feeding them...
Olivier Phan et al.
BioMed research international, 2015, 515606-515606 (2015-07-30)
Elevated serum phosphorus, calcium, and fibroblast growth factor 23 (FGF23) levels are associated with cardiovascular disease in chronic renal disease. This study evaluated the effects of sucroferric oxyhydroxide (PA21), a new iron-based phosphate binder, versus lanthanum carbonate (La) and sevelamer...
Articles
The prevailing strategies for heat and electric-power production that rely on fossil and fission fuels are having a negative impact on the environment and on our living conditions.
Read More

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.